Orchard Therapeutics plc Annual Depreciation in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Orchard Therapeutics plc annual/quarterly Depreciation history and growth rate from 2016 to 2022.
  • Orchard Therapeutics plc Depreciation for the quarter ending March 31, 2022 was $600K, a 20% increase year-over-year.
  • Orchard Therapeutics plc Depreciation for the twelve months ending March 31, 2022 was $2.3M, a 14% increase year-over-year.
  • Orchard Therapeutics plc annual Depreciation for 2022 was $2.4M, a 9.09% increase from 2021.
  • Orchard Therapeutics plc annual Depreciation for 2021 was $2.2M, a 10% increase from 2020.
  • Orchard Therapeutics plc annual Depreciation for 2020 was $2M, a 19.4% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.4M +$200K +9.09% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 $2.2M +$200K +10% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $2M +$325K +19.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $1.68M +$476K +39.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 $1.2M +$897K +297% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $302K +$296K +4933% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $6K Jan 1, 2016 Dec 31, 2016 20-F 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.